Pancreatic cancer uses a sugar-coated disguise to evade the immune system, helping explain why it’s so hard to treat.

Researchers found an antibody that seems to play a role in people with better lung cancer prognoses, but turning it into a ...

Two decades after a breast cancer vaccine trial, every participant is still alive—an astonishing result for metastatic ...

University of Southampton scientists have developed multi-pronged antibodies to boost T cell cancer response.

Retinoic acid suppresses immune defenses against cancer, but a new drug KyA33 boosts vaccine success and slows tumor growth in animal models.

New research suggests that a breast cancer vaccine developed decades ago may have triggered a lasting immune memory response that can now be significantly boosted by a newly developed antibody.

Knowable Magazine reports on advancements in pancreatic cancer treatment, including new drugs, vaccines, and early diagnostic ...

A newly identified metabolite in human feces improves immunotherapy and could radically change the treatment of lung cancer.

Researchers have evidence that inside shark DNA are single chain antibodies that just might help cure cancer. These flexible, “sticky” antibodies can grab onto cancer cells remarkably well, and hold ...

Researchers are edging closer to something long imagined but never quite within reach: a single vaccine platform that could be adapted to fight many kinds of cancer. Early experiments in animals and ...

The American Cancer Society (ACS) strongly supports the critical role of vaccination in promoting public health and protecting communities impacted by cancer. Vaccines are an essential part of care ...